Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

Share Price is delayed by 15 minutes
Get Live Data
134.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (1.504%)
Market Cap: £126.23m
TRU Live PriceLast checked at - London Stock Exchange

Intraday Trufin Plc Share Chart

Share Buyback Programme

22 May 2025 07:00

RNS Number : 7591J
TruFin PLC
22 May 2025
 

 

LEI: 213800C2QPZFECSRZ964

22 May 2025

 

 

TruFin plc

 ("TruFin" or the "Company" or together with its subsidiaries "TruFin Group" or the "Group")

 

 

Share Buyback Programme

 

 

TruFin (AIM: TRU) is pleased to announce the commencement of a share buyback programme ("Share Buyback Programme") to purchase ordinary shares of £0.91 each in the capital of the Company ("Ordinary Shares") up to a maximum aggregate consideration of £4 million (the "Maximum Amount").

 

As announced in the Group's trading update on 20 May 2025, the Share Buyback Programme is being initiated due to the Board's belief that the Company's shares trade at a discount to an internally calculated intrinsic value, in order to further enhance shareholder returns and to reduce the Company's share capital. Any Ordinary Shares acquired as a result of the Share Buyback Programme will be cancelled.

 

Details of the Buyback

 

The Group has entered into an agreement with its broker Panmure Liberum Limited ("Panmure Liberum") to carry out purchases of its Ordinary Shares under the Share Buyback Programme on its behalf. Panmure Liberum will manage the purchases on a discretionary basis, purchasing Ordinary Shares on the London Stock Exchange within certain pre-set parameters over the Share Buyback Programme up to the Maximum Amount.

 

Prior to the Company's next annual general meeting to be held on 12 June 2025 (the "2025 AGM"), the Share Buyback will take place within the limitations of the authority granted to the Board of TruFin at its annual general meeting ("General Authority"), held on 5 June 2024 (the "2024 AGM"), pursuant to which the maximum number of Ordinary Shares which may be bought back is 10,598,688, representing 10 per cent. of the Company's issued share capital. Thereafter, provided the relevant resolution is approved at the 2025 AGM, this limit will increase to 15,898,003, representing 15 per cent. of the Company's issue share capital.

 

In line with the authority given at the 2024 AGM, and the authority proposed at the 2025 AGM, the maximum price (exclusive of expenses) which may be paid for an Ordinary Share shall not be more than an amount equal to 105% of the average middle market quotations for an Ordinary Share, as derived from London Stock Exchange Daily Official List, for the five business days immediately preceding the day on which the Ordinary Share is contracted to be purchased.

 

Shareholders should be aware that the Share Buyback Programme may on any given trading day represent a significant portion of the daily traded volume in the Group's Ordinary Shares on the London Stock Exchange, and may exceed 25% (but not 50%) of the average daily traded volume on the London Stock Exchange during the 20 trading days preceding the date of purchase of such Ordinary Shares (the "Volume Limit"). Accordingly, the Group may not benefit from the exemption contained in Article 5(1) of MAR. The Volume Limit may be exceeded should Panmure Liberum consider, at its discretion, that an opportunity has arisen to acquire a significant number of shares in one trade. In such circumstances, an announcement of the purchase will be made as soon as possible following such trade taking place.

 

The Group has authorised the Share Buyback Programme to commence from today and will continue until the earlier of: (i) the date on which the Maximum Amount payable by the Company has been reached, or (ii) 31 August 2025, conditional on the share buyback authority being renewed at the Company's 2025 AGM.

 

Any market purchase of Ordinary Shares pursuant to the Share Buyback Programme will be announced no later than 7:30am (UK time) on the business day following the day on which the purchase occurred.

 

 

For further information, please contact:

 

TruFin plcJames van den Bergh, Chief Executive OfficerKam Bansil, Investor Relations

 

0203 743 134007779 229508

 

Panmure Liberum Limited (Nominated Adviser and Corporate broker)Chris ClarkeEdward Thomas

 

0203 100 2000

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEWSIEEISEFI
Date   Source Headline
20th Dec 20239:40 amRNSHolding(s) in Company
14th Dec 20237:00 amRNSAppointment of INED to the Board of Oxygen
21st Nov 20237:00 amRNSPlaystack enters into LoI for sale of Interact
9th Nov 20237:00 amRNSOxygen Finance acquisition of bidstats.uk
18th Oct 20234:19 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSSale of Majority Holding in Vertus
29th Sep 20237:00 amRNSHalf-year Report
28th Sep 202312:07 pmRNSResult of AGM
14th Sep 20238:00 amRNSPlaystack releases award-winning game - AK-xolotl
29th Aug 20236:19 pmRNSNotice of AGM
21st Aug 20237:00 amRNSNon-Binding Offer for Vertus
28th Jul 20237:00 amRNSGrant of Share Awards under LTIP
18th Jul 20238:59 amRNSHolding(s) in Company
18th Jul 20238:58 amRNSHolding(s) in Company
18th Jul 20238:55 amRNSHolding(s) in Company
10th Jul 202312:03 pmRNSResult of GM and Result of Placing and Open Offer
23rd Jun 20237:00 amRNSResult of Placing and Notice of General Meeting
22nd Jun 20234:45 pmRNSProposed Placing and Open Offer
18th May 20233:04 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSOxygen Finance secures six Early Payment contracts
15th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
28th Feb 20235:43 pmRNSHolding(s) in Company
23rd Jan 20237:00 amRNSStatement re Satago
20th Jan 20237:00 amRNSStatement regarding Satago and Trading Update
22nd Dec 20227:00 amRNSRejected Indicative Offer for Oxygen
15th Nov 20227:00 amRNSOxygen surpasses £1b in early payment provision
3rd Nov 20227:00 amRNSPlaystack releases new console game
20th Oct 20227:00 amRNSSatago signs agreement with Sage
10th Oct 20227:00 amRNSNotice of Capital Markets Day
30th Sep 20227:00 amRNSPDMR Notification
20th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Capital Markets Day
25th Aug 20229:37 amRNSHolding(s) in Company
29th Jul 20229:00 amRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSSatago signs commercial agreement with Lloyds
1st Jul 20227:00 amRNSHolding(s) in Company
9th Jun 20227:00 amRNSSatago partnership with Sage and Lloyds
7th Jun 202211:19 amRNSResult of AGM
6th Jun 20227:00 amRNSStatement re Playstack
4th May 20225:58 pmRNSNotice of AGM
29th Apr 20227:00 amRNSFinal Results For The Year Ended 31 December 2021
19th Apr 202212:04 pmRNSHolding(s) in Company
12th Apr 20225:53 pmRNSHolding(s) in Company
11th Apr 202210:18 amRNSResult of GM and Result of Placing and Open Offer
23rd Mar 20227:00 amRNSResult of Placing and Notice of General Meeting
22nd Mar 20224:51 pmRNSProposed Placing and Open Offer
9th Mar 20227:00 amRNSStatement re Satago
22nd Feb 20222:04 pmRNSVesting of JSOP Founder Awards
16th Feb 20227:00 amRNSDirectorate Change and Relationship Agreement
10th Dec 20217:00 amRNSStatement regarding Satago and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.